Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary V Doern

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
The Medical Clinics of North America|November 23, 2006
Macrolide and ketolide resistance with Streptococcus pneumoniaeGary V Doern
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 4, 2003
Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistanceGary V Doern
Expert Review of Anti-Infective Therapy|December 5, 2006
Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistanceGary V Doern
Journal of Clinical Microbiology|August 9, 2013
Antimicrobial stewardship programsKimberly D Leuthner, Gary V Doern
The Journal of Infection|December 12, 2003
Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01Gary V Doern, Steve D Brown
Journal of Clinical Microbiology|October 19, 2007
Comparison of three commercial test systems for biotyping Haemophilus influenzae and Haemophilus parainfluenzaeErik L Munson, Gary V Doern
Chest|November 13, 2004
In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistanceErik L Munson, Stephen O Heard, Gary V Doern
Diagnostic Microbiology and Infectious Disease|March 14, 2007
Oral beta-lactams in the treatment of acute otitis mediaStan L Block, Gary V Doern, Michael A Pfaller
Expert Opinion on Investigational Drugs|March 22, 2006
Optimal antimicrobial therapy: the balance of potency and exposureGlenn S Tillotson, Gary V Doern, Joseph M Blondeau
Infection Control and Hospital Epidemiology|July 16, 2005
Determining the clinical significance of coagulase-negative staphylococci isolated from blood culturesSusan E Beekmann, Daniel J Diekema, Gary V Doern
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
The Medical Clinics of North America|November 23, 2006
Macrolide and ketolide resistance with Streptococcus pneumoniaeGary V Doern
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 4, 2003
Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistanceGary V Doern
Expert Review of Anti-Infective Therapy|December 5, 2006
Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistanceGary V Doern
Journal of Clinical Microbiology|August 9, 2013
Antimicrobial stewardship programsKimberly D Leuthner, Gary V Doern
The Journal of Infection|December 12, 2003
Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01Gary V Doern, Steve D Brown
Journal of Clinical Microbiology|October 19, 2007
Comparison of three commercial test systems for biotyping Haemophilus influenzae and Haemophilus parainfluenzaeErik L Munson, Gary V Doern
Chest|November 13, 2004
In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistanceErik L Munson, Stephen O Heard, Gary V Doern
Diagnostic Microbiology and Infectious Disease|March 14, 2007
Oral beta-lactams in the treatment of acute otitis mediaStan L Block, Gary V Doern, Michael A Pfaller
Expert Opinion on Investigational Drugs|March 22, 2006
Optimal antimicrobial therapy: the balance of potency and exposureGlenn S Tillotson, Gary V Doern, Joseph M Blondeau
Infection Control and Hospital Epidemiology|July 16, 2005
Determining the clinical significance of coagulase-negative staphylococci isolated from blood culturesSusan E Beekmann, Daniel J Diekema, Gary V Doern
Pageof 6